Reporting the counterparty's growth as its own: management explains the company's coming year by narrating what its cust
The model's full reasoning — Q3 2016 call → NOThe question asks whether management explains the company's forward direction by narrating what its counterparties are themselves doing and scaling. I need to check if management's forward account consists of reporting on the growth, expansion, ramp, adoption, or program build-out of specific customers, partners, licensees, distributors, payers, operators, or programs the company already supplies or serves. Looking at the transcript, management discusses: - Strong demand in various end markets (electronics, medical, consumer non-durable) - Order rates up 16% in latest 12 weeks - Growth driven by new products, tiering, emerging market penetration - Advanced technology growth driven by mobile electronics, new dispense technology, waterproofing applications - Coatings business driven by automotive and consumer durable end markets However, management does NOT specifically narrate what identifiable counterparties are themselves doing - their own ramps, launches, rollouts, capacity additions, adoption curves, program phases, etc. Management speaks about end markets (mobile electronics, medical, automotive) and product lines, but doesn't describe specific customers' trajectories as the driver of Nordson's coming activity. Management's forward account is about: - Its own new products (tiered offerings, new dispense technology) - Its own market penetration - Its own continuous improvement initiatives - Broad end-market demand The counterparties mentioned (mobile electronics makers, medical device companies, automotive) are described in terms of demand for Nordson's products, not in terms of their own expansion trajectories that Nordson is embedded in. Management doesn't say "our customer is building X new facilities" or "our partner is rolling out Y" - it speaks about demand and orders. The answer is NO.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| EMKR | EMCORE Corporation | Q4 2023 | 2023-12-12 | C+ |
| MBLY | Mobileye Global Inc. | Q2 2023 | 2023-07-28 | B+ |
| PI | Impinj, Inc. | Q4 2022 | 2023-02-08 | B+ |
| FAT | FAT Brands Inc. | Q4 2021 | 2022-03-21 | F |
| OOMA | Ooma, Inc. | Q3 2022 | 2021-12-02 | B+ |
| ILMN | Illumina, Inc. | Q1 2018 | 2018-04-24 | A |
| PLAB | Photronics, Inc. | Q2 2017 | 2017-05-17 | C+ |
| IONS | Ionis Pharmaceuticals, Inc. | Q1 2017 | 2017-05-09 | C |
| FNV | Franco-Nevada Corporation | Q3 2016 | 2016-11-08 | B+ |
| HXL | Hexcel Corporation | Q4 2015 | 2016-01-22 | B+ |
OOMA · Q3 2022 → YESThe question is about whether management narrates what its counterparties are doing and scaling, presenting the company's future volume as a consequence of those parties' trajectories.
MBLY · Q2 2023 → YESThe question is about whether management narrates what its counterparties are doing and scaling, presenting the company's volume as a consequence of those parties' trajectories.
ILMN · Q1 2018 → YESThe question is about whether management narrates what its counterparties are doing and scaling, presenting the company's future as a consequence of those parties' trajectories.